DCR-PDL1

· Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DCR-PDL1, covering 2025-11-06 to 2025-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors [Phase 1]